DC’s pharmacy board scraps MR payment disclosure rule
The board now says disclosure is not necessary so long as research is conducted by an independent agency that is neither owned nor affiliated to a pharmaceutical manufacturer, that the drug company does not know the identity of the respondent and that payments are made by the survey company.
Disclosure rules for marketing payments were brought in with the state’s AccessRx Act of 2004. Although the act itself did not apply to market research payments, the Board of Pharmacy decided to extend the reporting requirements.
The revised rules were announced by the Council for American Survey Research Organisations (Casro), who spent six months lobbying for the change.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments